Emma Taggart - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Emma Taggart

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Frontiers in Genetics|April 18, 2022

Decosus: An R Framework for Universal Integration of Cell Proportion Estimation MethodsChinedu A Anene, Emma Taggart, Catherine A Harwood, et al.

Cancer Immunology Research|October 1, 2020

An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor RegressionRichard C A Sainson, Anil K Thotakura, Miha Kosmac, et al.

Cancer Cell|January 17, 2025

A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancerAmelia Acha-Sagredo, Pietro Andrei, Kalum Clayton, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Frontiers in Genetics|April 18, 2022

Decosus: An R Framework for Universal Integration of Cell Proportion Estimation MethodsChinedu A Anene, Emma Taggart, Catherine A Harwood, et al.

Cancer Immunology Research|October 1, 2020

An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor RegressionRichard C A Sainson, Anil K Thotakura, Miha Kosmac, et al.

Cancer Cell|January 17, 2025

A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancerAmelia Acha-Sagredo, Pietro Andrei, Kalum Clayton, et al.

Pageof 1